Oliver A. Cornely

Professor Oliver A. Cornely holds dual leadership roles at the University of Cologne as Director of the Institute for Translational Research at the CECAD Cluster of Excellence and Scientific Director of the Center for Clinical Studies (ZKS) Cologne at the University Hospital of Cologne and Faculty of Medicine. His work bridges laboratory science and clinical application to advance medical treatments.

His research focuses on critical intersections of:

• Infectious Diseases - particularly fungal and bacterial pathogens
• Oncology - managing infections in immunocompromised cancer patients
• Translational Medicine - accelerating lab discoveries into clinical practice
• Antimicrobial Therapy - optimizing treatment protocols

Professor Cornely received the prestigious Dr. Gerald P. Bodey, Sr., Memorial Distinguished Visiting Professorship Award from MD Anderson Cancer Center, honoring exceptional contributions to infectious disease research and clinical teaching. This award recognizes his leadership in developing evidence-based guidelines for infection management in oncology.

He directs the Institute for Translational Research which drives collaborative projects between basic scientists and clinicians to address urgent challenges in patient care, with particular emphasis on improving outcomes for immunocompromised populations through innovative clinical trial designs and biomarker development.